2016 tables: Institutions - chemistry - corporate

The 2016 tables are based on Nature Index data from 1 January 2015 to 31 December 2015.

Table criteria

# Institution Share 2015 Count 2015
1 IBM Corporation, United States of America (USA) 22.48 41
2 Merck & Co., Inc., United States of America (USA) 16.85 28
3 Novartis International AG, Switzerland 14.96 34
4 GlaxoSmithKline plc. (GSK), United Kingdom (UK) 14.40 34
5 AstraZeneca plc, United Kingdom (UK) 13.10 48
6 Pfizer Inc., United States of America (USA) 10.17 20
7 F. Hoffmann-La Roche AG, Switzerland 8.82 23
8 Toyota Group, Japan 8.69 18
9 Bristol-Myers Squibb (BMS), United States of America (USA) 7.75 11
10 Dow Inc., United States of America (USA) 7.39 31
11 BASF SE, Germany 7.30 42
12 C. H. Boehringer Sohn AG & Co. KG (Boehringer Ingelheim), Germany 6.75 11
13 Samsung Group, South Korea 6.56 27
14 Amgen Inc., United States of America (USA) 5.53 8
15 Bruker Corporation, United States of America (USA) 4.59 32
16 Sanofi, France 4.48 10
17 Waters Corporation, United States of America (USA) 4.44 12
18 Thermo Fisher Scientific Inc., United States of America (USA) 4.40 15
19 China National Chemical Corporation (ChemChina), China 4.17 12
20 Takeda Pharmaceutical Company Limited, Japan 3.81 10
21 Koninklijke DSM N.V. (DSM), Netherlands 3.70 8
22 Danaher Corporation, United States of America (USA) 3.54 9
23 Johnson & Johnson, United States of America (USA) 3.41 9
24 Eli Lilly and Company, United States of America (USA) 3.40 8
25 Hitachi, Ltd., Japan 3.13 16
26 Alexion Pharmaceuticals, Inc., United States of America (USA) 3.00 3
27 Johnson Matthey (JM), United Kingdom (UK) 2.99 5
28 Center for Nanotechnology GmbH (CeNTech GmbH), Germany 2.89 12
29 Mitsubishi Group, Japan 2.77 20
30 General Electric Company (GE), United States of America (USA) 2.52 5
31 Formosa Plastics Group, Taiwan 2.32 8
32 Merck KGaA, Germany 2.23 13
33 Vertex Pharmaceuticals Incorporated, United States of America (USA) 2.12 4
34 Promega Corporation, United States of America (USA) 2.12 4
35 Agilent Technologies, Inc., United States of America (USA) 2.06 7
36 Austrian Centre of Industrial Biotechnology (ACIB), Austria 2.04 5
37 Chevron Corporation, United States of America (USA) 2.02 8
38 Chengdu Institute of Organic Chemistry (CIOC), CAS, China 1.99 5
39 Xerox Corporation, United States of America (USA) 1.97 6
40 Leidos Holdings, Inc., United States of America (USA) 1.87 14
41 Eisai Co., Ltd., Japan 1.84 7
42 D. E. Shaw Research, United States of America (USA) 1.80 5
43 Peptide Institute, Inc., Japan 1.75 2
44 Gilead Sciences, Inc., United States of America (USA) 1.71 3
45 Nippon Telegraph and Telephone Corporation (NTT), Japan 1.69 3
46 New England Biolabs, Inc. (NEB), United States of America (USA) 1.67 4
47 Exxon Mobil Corporation (ExxonMobil), United States of America (USA) 1.66 21
48 FiberHome Technologies Group, China 1.65 15
48 China Shipbuilding Industry Corporation (CSIC), China 1.65 15
49 Novo Nordisk A/S, Denmark 1.55 4
50 Konica Minolta, Inc., Japan 1.55 3

Footnote

Each year, the Nature Index publishes tables based on counts of high-quality research outputs in the previous calendar year. Users please note:

  1. The data behind the tables are based on a relatively small proportion of total research papers, they cover the natural sciences only and outputs are non-normalized (that is, they don’t reflect the size of the country or institution, or its overall research output).
  2. The Nature Index is one indicator of institutional research performance. The metrics of Count and Share used to order Nature Index listings are based on an institution’s or country’s publication output in 82 natural-science journals, selected on reputation by an independent panel of leading scientists in their fields.
  3. Nature Index recognizes that many other factors must be taken into account when considering research quality and institutional performance; Nature Index metrics alone should not be used to assess institutions or individuals.
  4. Nature Index data and methods are transparent and available under a creative commons licence at natureindex.com.

The Nature Index database undergoes regular updating, corrections, adjustment of institutional hierarchies, and removal of retracted papers and thus the live website can differ from the frozen annual tables.